Set as Homepage - Bookmark This Page   
You are here:Home >Markets >Immix... recnac latceroloc ni 011-XMI r Content

Immix... recnac latceroloc ni 011-XMI r

Source: Sanctum InfinityEditor: MarketsDate: 2025-06-09 21:40:04
Immix Biopharma (NASDAQ:IMMX) reported early interim data from a phase 1b/2a trial of IMX-110 in combination with Novartis (NYSE:NVS) and BeiGene's (NASDAQ:BGNE) tislelizumab to treat patients with ad... Stay informed with the latest.

0.2744s , 6840.0625 kb

Copyright © 2025 Powered by Immix... recnac latceroloc ni 011-XMI r,Sanctum Infinity  

sitemap

Top